Back
MiNK Therapeutics Stock Predictions
Sell
46
INKT
MiNK Therapeutics
Last Price:
1.01
Seasonality Move:
19.48%
7 Day Trial
ALL ACCESS PASS
$
7
MiNK Therapeutics Stock Forecast
-
Is MiNK Therapeutics Stock Undervalued?
The current MiNK Therapeutics [INKT] share price is $1.01. The Score for INKT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal. - INKT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will MiNK Therapeutics Stock Go Up Next Year?
Data Unavailable
MiNK Therapeutics Stock Rating
Data Unavailable
MiNK Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
minktherapeutics.com
52-Week Data
52-Week High:
3.34
52-Week Low:
0.75
Prediction Charts
Market Cap:
35.07M
Price in USD:
1.01
Volume:
68.73K
Beta:
0.04
Technical Analysis
SMA50:
0.96
SMA100:
0.95
SMA200:
1.09
52-Wk Change:
-43.89%
Stock Predictions
-
Is MiNK Therapeutics stock public?
Yes, MiNK Therapeutics is a publicly traded company. -
What is the MiNK Therapeutics stock quote today?
The MiNK Therapeutics stock price is 1.01 USD today. -
How to buy MiNK Therapeutics stock online?
You can buy MiNK Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-30 | 0.99 | 0.97 | 0.99 | 0.93 |
| May-1 | 0.99 | 0.95 | 0.99 | 0.93 |
| May-2 | 0.95 | 0.97 | 0.97 | 0.92 |
| May-3 | 0.99 | 0.98 | 0.99 | 0.94 |
| May-6 | 0.98 | 0.95 | 1.01 | 0.94 |
| May-7 | 0.94 | 0.93 | 0.98 | 0.92 |
| May-8 | 0.93 | 0.93 | 0.95 | 0.92 |
| May-9 | 0.93 | 0.90 | 0.93 | 0.86 |
| May-10 | 0.92 | 0.90 | 0.92 | 0.89 |
| May-13 | 1.04 | 0.98 | 1.08 | 0.95 |
| May-14 | 0.97 | 1.12 | 1.16 | 0.97 |
| May-15 | 1.09 | 1.04 | 1.30 | 0.93 |
| May-16 | 1.06 | 1.04 | 1.10 | 0.98 |
| May-17 | 1.02 | 1.01 | 1.04 | 0.98 |
MiNK Therapeutics Earnings
Data Unavailable
MiNK Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.05 per share.
* MiNK Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.